Exploring an Integrative Therapy for Treating COVID-19: A Randomized Controlled Trial

ConclusionsKeguan-1-based integrative therapy was safe and superior to the standard therapy in suppressing the development of ARDS in COVID-19 patients. (Trial registration No. NCT 04251871 atwww.clinicaltrials.gov)

Source: Chinese Journal of Integrative Medicine - July 15, 2020 Category: Internal Medicine Source Type: research